GCC
PFE icon

Game Creek Capital’s Pfizer PFE Stock Holding History

Game Creek Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-60,000
Closed -$3.54M – 79
2021
Q4 		$3.54M Sell
60,000
-15,000
-20% -$743K 1.47% 22
2021
Q3 		$3.23M Buy
+75,000
New +$3.32M 1.39% 25

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Game Creek Capital's PFE Position: Q2 2026 in Review

Game Creek Capital reduced its Pfizer (PFE) stake by 39% in Q2 2026, selling an estimated $1.36M and leaving 82,500 shares worth $1.99M. The position accounts for 0.7% of the portfolio, ranked #44.

Game Creek Capital first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $16.1M in Q4 2021. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Game Creek Capital held 82,500 shares of Pfizer worth $1.99M as of Q2 2026.
  • Game Creek Capital sold 51,875 Pfizer shares in Q2 2026, an estimated $1.36M.
  • Pfizer made up 0.7% of Game Creek Capital's portfolio in Q2 2026, its #44 holding.
  • Game Creek Capital first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
  • Game Creek Capital's Pfizer position peaked at $16.1M in Q4 2021.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Game Creek Capital's 13F filing for Q2 2026, filed 13 Aug 2026.